Fundraising Fox

Markus Enzelberger

Investor

Partner at Versant Ventures

Munich, Germany

Writes $100K – $5M checks · typically $1.5M

About

Markus is a Versant partner in Basel who helps launch new companies from the firm's Ridgeline Discovery Engine. A drug discovery and protein engineering expert, he previously served as CSO and management board member of MorphoSys, which he joined in 2002, and holds a Ph.D. from the Technical University of Stuttgart.

Contact· self-published, not guessed

Experience

  1. Versant VenturesPartnercurrent2020 — presentBasel, Basel, Switzerland
  2. Versant VenturesEntrepreneur in Residence2020Basel, Basel, Switzerland
  3. Granite BioBoard Membercurrent2021 — presentBasel, Switzerland
  4. Serac BiosciencesBoard Membercurrent2023 — present
  5. Red Ridge BioBoard Membercurrent2024 — presentBasel, Switzerland
  6. Abdera TherapeuticsBoard Observercurrent2021 — present
  7. Ridgeline DiscoveryBoard Membercurrent2020 — present
  8. Cimeio TherapeuticsBoard Membercurrent2020 — present
  9. SHS CapitalSenior Advisorcurrent2017 — present
  10. T-knifeBoard Observercurrent2020 — present
  11. SixPeaks BioBoard Member2023 — 2025Basel, Switzerland
  12. Matterhorn BiosciencesBoard Member2022 — 2025Basel, Switzerland
  13. Develco Pharma Schweiz AGAufsichtsratsmitglied2022 — 2024Basel, Switzerland
  14. Vertical BioscienceBoard Member2020 — 2023Basel
  15. Vector BioPharmaBoard Member2020 — 2023
  16. GNA Biosolutions GmbHAufsichtsratsmitglied2018 — 2021Martinsried
  17. MorphoSys AGCSO2017 — 2020Greater Munich Metropolitan Area
  18. MorphoSys AGinterim-CSO2017Greater Munich Metropolitan Area
  19. MorphoSys AGSenior Vice President2002 — 2017Greater Munich Metropolitan Area
  20. MorphoSys AGVice President2002 — 2012

Skills & more

Pharmaforschung4Biowissenschaften10Biotechnologie13Pharmaindustrie14Molekularbiologie10Technologietransfer7Biochemie4Biopharmazeutika1Immunologie2Arzneimittelentwicklung7BiokatalyseAntikörper2
+8 moreProteinchemieForschung und EntwicklungTechnology TransferClinical DevelopmentOnkologieBiopharmaceuticalsBiotechnologyTechnology

From Markus's professional profile.

Colleagues at Versant Ventures

Frequently asked questions

Who is Markus Enzelberger?
Markus is a Versant partner in Basel who helps launch new companies from the firm's Ridgeline Discovery Engine. A drug discovery and protein engineering expert, he previously served as CSO and management board member of MorphoSys, which he joined in 2002, and holds a Ph.D. from the Technical University of Stuttgart.
Where does Markus Enzelberger work?
Markus Enzelberger is Partner at Versant Ventures.
What check size does Markus Enzelberger write?
Markus Enzelberger typically writes checks of $100K – $5M.
Where did Markus Enzelberger go to school?
Markus Enzelberger studied at Caltech (Postdoc, Applied Physics); University of Stuttgart (Promotion, Chemie).

Same school

Shared employers